Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trametinib in Pediatric Glioma or Plexiform Neurofibroma
NCT03363217Phase 2Active, not recruiting
- Sponsor
- Centre Hospitalier Universitaire Sainte-Justine
- Start
- Aug 2018
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trametinib in glioma, plexiform neurofibroma (PN), sponsored by Centre Hospitalier Universitaire Sainte-Justine. Started Aug 2018; status: active, not recruiting.
02
Drugs
trametinib
03
Conditions
gliomaplexiform neurofibroma (PN)
Beyond the preview
Go deeper on NCT03363217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03363217.